SEC Comment Letter 0000000000-23-003871 to AVITA Medical, Inc. (RCEL)

AVITA Medical, Inc.
Date: April 18, 2023 · CIK: 0001762303 · Accession: 0000000000-23-003871

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-271276

Date

April 18, 2023

Author

Sean Ekins

Form

UPLOAD

Company

AVITA Medical, Inc.

Letter

United States securities and exchange commission logo April 18, 2023 Sean Ekins Chief Financial Officer AVITA Medical, Inc. 28159 Avenue Stanford, Suite 220 Valencia, CA 91355 Re:AVITA Medical, Inc. Registration Statement on form S-3 Filed on April 14, 2023 File No. 333-271276 Dear Sean Ekins: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Nicholas O'Leary at (202) 551-4451 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Christopher Cunningham

Show Raw Text

United States securities and exchange commission logo
April 18, 2023
Sean Ekins
Chief Financial Officer
AVITA Medical, Inc.
28159 Avenue Stanford, Suite 220
Valencia, CA 91355
Re:AVITA Medical, Inc.
Registration Statement on form S-3
Filed on April 14, 2023
File No. 333-271276
Dear Sean Ekins:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Nicholas O'Leary at (202) 551-4451 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:       Christopher Cunningham

SecProbe.io